The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 04, 2016
Filed:
Oct. 06, 2014
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Shawn Stachel, Perkasie, PA (US);
Daniel V. Paone, Lansdale, PA (US);
Jing Li, Lansdale, PA (US);
Kausik Nanda, Norristown, PA (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/421 (2006.01); C07D 263/32 (2006.01); C07D 263/34 (2006.01); C07D 277/30 (2006.01); C07D 413/04 (2006.01); C07D 413/10 (2006.01); C07D 417/10 (2006.01); C07D 417/14 (2006.01); C07D 495/08 (2006.01); C07F 7/08 (2006.01); A61K 31/695 (2006.01); A61K 31/422 (2006.01); A61K 31/547 (2006.01); A61K 31/541 (2006.01); A61K 31/5377 (2006.01); A61K 31/496 (2006.01); C07D 513/08 (2006.01); A61K 31/427 (2006.01); A61K 45/06 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07F 7/0807 (2013.01); A61K 31/421 (2013.01); A61K 31/422 (2013.01); A61K 31/427 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 31/547 (2013.01); A61K 31/695 (2013.01); A61K 45/06 (2013.01); C07D 263/32 (2013.01); C07D 263/34 (2013.01); C07D 277/30 (2013.01); C07D 413/04 (2013.01); C07D 413/10 (2013.01); C07D 413/12 (2013.01); C07D 417/10 (2013.01); C07D 417/14 (2013.01); C07D 495/08 (2013.01); C07D 513/08 (2013.01);
Abstract
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.